• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. CARBOFLO VASCULAR GRAFT; EPTFE VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. CARBOFLO VASCULAR GRAFT; EPTFE VASCULAR GRAFT Back to Search Results
Catalog Number F8006TWSC
Device Problem Torn Material (3024)
Patient Problem No Patient Involvement (2645)
Event Date 04/10/2014
Event Type  malfunction  
Manufacturer Narrative
A further clinical review of the event details was completed and a change in the mdr reportability was identified.No medical records or no medical images have been made available to the manufacturer.As the serial number for the device was provided, a review of the device history records is currently being performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.
 
Event Description
It was reported that during preparation the surgical graft tore, a new surgical graft was implanted.There is no reported patient contact.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was conducted.The lot met all release criteria.Visual inspection(s): segment 1: segment 1 appeared clean.The graft segment had two blue lines running longitudinally down the graft and had carbon lining, which identified the product as a bard graft.The segment measured approximately 78.8cm long.The beading was unraveled at one end of the segment for 12.4cm.One partial circumferential tear was observed along the beading track where the beading had been removed.The tear was located approximately 1.4cm from the edge of the segment.There were no signs of stretching at the locations of the tears.The removed beading was still attached to the segment of graft.Both ends of the segment have uneven cuts.Segment 2: segment 2 appeared clean.The graft segment had two blue lines running longitudinally down the graft and had carbon lining, which identified the product as a bard graft.The segment measured approximately 2.7cm long.The beading was unraveled at one end of the segment for 8.8cm.Two partial circumferential tears were observed along the beading track where the beading had been removed.The tears were located approximately 0.9cm and 1.2cm from the edge of the segment.There were no signs of stretching at the locations of the tears.The removed beading was still attached to the graft.End of segment with unraveled beading has even cut, other end of segment has uneven cut.Dimensional evaluation: the length of the graft measured approximately 81.5cm.This measurement was within specification.Medical records review: as medical records were not provided, a review could not be performed.Image/photo review: no medical images have been made available to the manufacturer.Conclusion: the investigation is confirmed for torn material, as a partial circumferential tears were observed along the beading track of segment 1 and segment 2.The root cause could not be determined based upon available information.It is unknown whether procedural factors contributed to the event.Labeling review: the current ifu (instructions for use) states: warnings: impra® eptfe grafts do not stretch (are non-elastic) in the longitudinal direction.The correct graft length for each procedure must be determined by considering the patient¿s body weight, posture, and the range of motions across the anatomical area of graft implantation.Failure to cut the grafts to an appropriate length may result in anastomotic or graft disruption, leading to excessive bleeding, and loss of limb or limb function, and/or death.Aggressive and/or excessive graft manipulation when tunneling, or placement within a too tight or too small tunnel, may lead to separation of the spiral beading and/or graft breakage.Avoid repeated or excessive clamping at the same location on the graft.If clamping is necessary, use only atraumatic or appropriate vascular smooth jawed clamps to avoid damage to the graft wall.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARBOFLO VASCULAR GRAFT
Type of Device
EPTFE VASCULAR GRAFT
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer (Section G)
BARD PERIPHERAL VASCULAR, INC.
1625 west 3rd st.
tempe AZ 85281
Manufacturer Contact
judith ludwig
1625 west 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key5356898
MDR Text Key35996178
Report Number2020394-2016-00072
Device Sequence Number1
Product Code DYF
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K004012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/16/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/11/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2018
Device Catalogue NumberF8006TWSC
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/01/2014
Is the Reporter a Health Professional? No
Date Manufacturer Received03/22/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/23/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-